American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA.
Tear
Steven
S
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE UK. steven.tear@thomson.com
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006405:Hematology / Q000639:trends*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D046988:Proteasome Endopeptidase Complex / Q000187:drug effects; D019009:Proto-Oncogene Proteins c-kit / Q000187:drug effects; D013449:Sulfonamides / Q000627:therapeutic use; D000077204:Temozolomide
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D006834:Hydrazines; D013449:Sulfonamides; C483604:laromustine; D003606:Dacarbazine; D019009:Proto-Oncogene Proteins c-kit; D046988:Proteasome Endopeptidase Complex; D000077204:Temozolomide